Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP946420.RAdMCB3Zq1fHMEYXvPlkXrRvOFVHWzyUbrsrisKYJg580130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP946420.RAdMCB3Zq1fHMEYXvPlkXrRvOFVHWzyUbrsrisKYJg580130_assertion type Assertion NP946420.RAdMCB3Zq1fHMEYXvPlkXrRvOFVHWzyUbrsrisKYJg580130_head.
- NP946420.RAdMCB3Zq1fHMEYXvPlkXrRvOFVHWzyUbrsrisKYJg580130_assertion description "[Importantly, PEAK1 inactivation sensitized PDAC cells to trastuzumab and gemcitabine therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP946420.RAdMCB3Zq1fHMEYXvPlkXrRvOFVHWzyUbrsrisKYJg580130_provenance.
- NP946420.RAdMCB3Zq1fHMEYXvPlkXrRvOFVHWzyUbrsrisKYJg580130_assertion evidence source_evidence_literature NP946420.RAdMCB3Zq1fHMEYXvPlkXrRvOFVHWzyUbrsrisKYJg580130_provenance.
- NP946420.RAdMCB3Zq1fHMEYXvPlkXrRvOFVHWzyUbrsrisKYJg580130_assertion SIO_000772 22589274 NP946420.RAdMCB3Zq1fHMEYXvPlkXrRvOFVHWzyUbrsrisKYJg580130_provenance.
- NP946420.RAdMCB3Zq1fHMEYXvPlkXrRvOFVHWzyUbrsrisKYJg580130_assertion wasDerivedFrom befree-20150227 NP946420.RAdMCB3Zq1fHMEYXvPlkXrRvOFVHWzyUbrsrisKYJg580130_provenance.
- NP946420.RAdMCB3Zq1fHMEYXvPlkXrRvOFVHWzyUbrsrisKYJg580130_assertion wasGeneratedBy ECO_0000203 NP946420.RAdMCB3Zq1fHMEYXvPlkXrRvOFVHWzyUbrsrisKYJg580130_provenance.